Systemic sclerosis-Reference-Cited by-同舟云学术

Systemic sclerosis

Published:2015-05 Issue:3 Volume:27 Page:241-248
ISSN:1040-8711
Container-title:Current Opinion in Rheumatology
language:en
Short-container-title:

Author:

Young Amber,Khanna Dinesh

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rheumatology

Reference45 articles.

1. Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.;Quillinan;Ann Rheum Dis,2014

2. Immunotherapy of systemic sclerosis.;Manno;Immunotherapy,2010

3. A randomized, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis.;Takehara;Clin Exp Rheumatol,2013

4. Intravenous immunoglobulin may be an effective therapy for refractory, active diffuse cutaneous systemic sclerosis.;Poelman;J Rheumatol,2015

5. Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.;Prey;Br J Dermatol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud’s Phenomenon in the Lifelines Population: Focus on Pulmonary Complications;Diagnostics;2023-06-25

2. Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases;Antioxidants;2023-03-25

3. IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis;Journal of Investigative Dermatology;2022-10

4. Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients;Frontiers in Immunology;2022-07-22

5. Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis;The Journal of Immunology;2022-07-01